Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03359421 · ClinicalTrials.gov registry record
Trauma Routing Algorithm for Pediatrics
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 4,801
- Enrollment target
NCT03359421: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03359421 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 4,801 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03359421 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 4,801 participants
- Enrollment target
Study Summary
Traumatic injury is the leading cause of pediatric death in the United States for those forty-four years of age and younger. Pediatric trauma patients generally have reduced mortality when treated at pediatric trauma centers rather than at adult centers or non-tertiary care facilities. However, nearly half the US pediatric population lives over fifty miles from a Level I or II Trauma Center. While air ambulances are readily available in many jurisdictions, few guidelines and little evidence dictate their appropriate use, especially with regard to pediatric trauma. Previous research is mixed regarding mortality benefit from helicopter Emergency Medical Services (EMS) in injured children. Previous attempts to develop appropriate field triage criteria have failed due to poor sensitivity and specificity for identifying the critically injured child. The current high rate of overtriage is particularly concerning in today's cost-conscious medical community. This research study aims to categorize pre-hospital pediatric trauma in North Carolina, to determine what benefits helicopter EMS provides in the North Carolina trauma system, and to formulate an enhanced screening tool for pre-hospital use to help determine which patients are suitable candidates for helicopter EMS transport.
Primary Outcome
Patient survival
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,801 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2020-05-31 |
What the finished NCT03359421 record still lists
NCT03359421 is an observational study that tracks outcomes without assigning an intervention. Its 4,801 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03359421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03359421 about?
NCT03359421 is a clinical study titled "Trauma Routing Algorithm for Pediatrics". Traumatic injury is the leading cause of pediatric death in the United States for those forty-four years of age and younger. Pediatric trauma patients generally have reduced mortality when treated at pediatric trauma centers rather than at adult centers or non-tertiary care facilities. However, near...
What is the current status of trial NCT03359421?
This trial is currently completed. The enrollment target is 4,801 participants. The study started on 2017-11-27. Estimated completion is 2020-05-31.
Who is sponsoring clinical trial NCT03359421?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI